Methadone to buprenorphine/naloxone induction without withdrawal utilizing transdermal fentanyl bridge in an inpatient setting—Azar method

P Azar, M Nikoo, I Miles - The American Journal on Addictions, 2018 - Wiley Online Library
Background and Objectives Although buprenorphine/naloxone is widely recognized as first‐
line therapy for opioid use disorder, the requirement for moderate withdrawal prior to …
被引用次数：25 相关文章

Methadone to buprenorphine/naloxone induction without withdrawal utilizing transdermal fentanyl bridge in an inpatient setting-Azar method

P Azar, M Nikoo, I Miles - The American journal on …, 2018 - pubmed.ncbi.nlm.nih.gov
Background and objectives Although buprenorphine/naloxone is widely recognized as first-
line therapy for opioid use disorder, the requirement for moderate withdrawal prior to …

Methadone to buprenorphine/naloxone induction without withdrawal utilizing transdermal fentanyl bridge in an inpatient setting-Azar method.

P Azar, M Nikoo, I Miles - The American Journal on Addictions, 2018 - europepmc.org
Methods We present a case utilizing transdermal fentanyl as a bridging treatment to
eliminate withdrawal during the transition from methadone to buprenorphine/naloxone in a …